TrialJAMA neurology2020

Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial.

Stephen Mullin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.